Poisoning News and Research

RSS

Genetically engineered bugs to fight cancer

GENETICALLY engineered bacteria could become the latest weapons against cancer, Cancer Research UK scientists suggest in a study published today 22nd April 2004.

22 Apr 2004

No relationship between HIV and oral polio vaccine

HIV-AIDS did not come from oral polio vaccine contaminated with chimpanzee virus, reports a research team led by a University of Arizona evolutionary biologist

21 Apr 2004

76 million people get sick in US, 300,000 are hospitalized, and 5,000 die from foodborne illness

Foodborne illnesses have a major public health impact in the United States. It is estimated that each year in the United States, 76 million people get sick, more than 300,000 are hospitalized, and 5,000 die as a result of foodborne illnesses, primarily the very young, elderly, and the immunocompromised.

18 Apr 2004

Microbiologists have characterised the DNA in bacteria responsible for vomiting

James Cook University microbiologists have characterised the DNA in bacteria responsible for one of the world's most common forms of food poisoning.

16 Apr 2004

San Diego seawater contains neurotoxin that can poison human consumers of shellfish

Researchers at Scripps Institution of Oceanography at the University of California, San Diego, have documented for the first time in San Diego seawater the presence of a neurotoxin that has been known to poison marine mammals, birds and human consumers of shellfish.

12 Apr 2004

Effects of lead in petrol are well-known however a recent additive to petrol manganese may be just as toxic

The disastrous environmental and health effects of lead in petrol are well-known, and western countries have been phasing it out for many years now. However, a recent additive to petrol - manganese - may be just as toxic. A Macquarie University study aims to find out.

7 Apr 2004

First large-scale clinical trial of chelation therapy, a controversial treatment for heart disease

NYU Medical Center has begun enrolling patients in the first large-scale clinical trial of chelation therapy, a controversial treatment for heart disease widely practiced by complementary and alternative medicine physicians. The new, government-funded nationwide study will determine whether the therapy benefits people with coronary artery disease, the leading cause of death for both men and women in the United States.

30 Mar 2004